Loading…

0-46. The availability of oestrogen receptor (ER) status strongly influences recommendations for adjuvant systemic therapy in higher risk breast cancer patients

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) 1997-08, Vol.6 (4), p.237-238
Main Authors: Wishart, G.C., Harnett, A.N., Purushotham, A.D.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0960-9776
1532-3080
DOI:10.1016/S0960-9776(97)90627-5